Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
NCT01842594Phase 2Terminated
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Start
- Aug 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydroxychloroquine and sirolimus in soft tissue sarcoma (STS), sponsored by Shin Kong Wu Ho-Su Memorial Hospital. Primary endpoint: Maximum Standardized Uptake Values Change on PET/CT Scan at 2 weeks. Started Aug 2012; status: terminated.
02
Drugs
hydroxychloroquinesirolimus
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01842594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01842594.